© 2021 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Reflector
Articles
Long-View Innovation Hopes for Pharma Policy in the EU
Draft plan looks beyond the immediate European health challenges.
COVID-19 Catalyzing Changes in European Medicines Regulation
Latest proposal explores boosting the powers of the EMA.
The Fight for Orphan Drug Research Reform in Europe
Can private sector serve public interests in battling rare diseases?
Following Through on ‘New-Era’ Boasts for European Health Policy
EU tasked with translating bold declarations into reality.